Falco Holdings Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Falco Holdings Co Ltd with three other
pharmaceutical manufacturers in Asia:
Medical & Biological Laboratories Company Limited
sales of 7.35 billion Japanese Yen [US$68.93 million]
of which 99%
was Reagent business),
Thyrocare Technologies Ltd
(3.07 billion Indian Rupees [US$47.31 million]
of which 89%
was Diagnostic Testing Services), and
Dr. Lal PathLabs Ltd
based in India
(9.12 billion Indian Rupees [US$140.69 million]
of which 100%
Falco Holdings Co Ltd reported sales of ¥45.97 billion (US$431.21 million)
March of 2017.
decrease of 5.7%
versus 2016, when the company's sales were ¥48.73 billion.
Contributing to the drop in overall sales was the 9.8% decline
in Preparation of Drugs, from ¥20.09 billion to ¥18.12 billion.
There were also decreases in sales in
Medical Test (down 2.8% to ¥27.85 billion)